ContributorsPublishersAdvertisers

Impact of the IMpower133 Trial in Small Cell Lung Cancer

targetedonc.com
 2022-01-08

Cover picture for the articleLeora Horn, MD, discusses the importance of the Impower133 trial. Leora Horn, MD, global clinical head for Lung Cancer and Lung Cancer Strategy at AstraZeneca, discusses the importance of the Impower133 trial (NCT02763579) trial of carboplatin plus etoposide with or without atezolizumab (Tecentriq) in patients with small cell lung...

www.targetedonc.com

Comments / 0

Comments / 0